1.15
1.71%
-0.02
Adaptimmune Therapeutics Plc ADR Aktie (ADAP) Neueste Nachrichten
Adaptimmune (ADAP) Down on End of Collaboration With Roche
Zacks Investment Research
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday
Benzinga
Adaptimmune Therapeutics PLC (ADAP) Stock Moves -1.24%: What You Should Know
Zacks Investment Research
Adaptimmune (ADAP) Surges More Than 80% in a Month: Here's Why
Zacks Investment Research
Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND
Zacks Investment Research
Kapitalisierung:
|
Volumen (24h):